Home » Topics » Regulatory » Patents

Patents
RSS

T2YC presents new integrin modulators

Feb. 21, 2022

Guangzhou Henovcom Bioscience discloses new antivirals

Feb. 21, 2022

Shaanxi Synthetic Pharmaceutical divulges new antiarthritic drugs

Feb. 21, 2022

BioWorld MedTech Patent Highlights: Week 6

From Current Patent Gazette

Feb. 18, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

New HSD17B13 inhibitors identified at Inipharm

Feb. 18, 2022

Fog Pharmaceuticals describes stapled peptides targeting beta-catenin

Feb. 18, 2022

New SREBP inhibitors identified at Capulus Therapeutics

Feb. 18, 2022

Merck & Co. presents new adenosine A2A and/or A2B receptor antagonists

Feb. 18, 2022

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Feb. 18, 2022

Angion Biomedica divulges new ROCK1/ROCK2 inhibitors

Feb. 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.